Becton Dickinson Return on Tangible Equity 2012-2026 | BDX
Current and historical return on tangible equity values for Becton Dickinson (BDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Unlock Macrotrends Premium
Start 7-Day Free Trial
Becton Dickinson Return On Tangible Equity Historical Data
Date
TTM Net Income
Tangible Equity
Return on Tangible Equity
2026-06-30
$0.94B
$-9.97B
-9.44%
2026-03-31
$1.14B
$-10.31B
-11.04%
2025-12-31
$1.76B
$-10.60B
-16.57%
2025-09-30
$1.68B
$-10.92B
-15.37%
2025-06-30
$1.59B
$-11.34B
-13.98%
2025-03-31
$1.50B
$-10.76B
-13.92%
2024-12-31
$1.73B
$-10.22B
-16.90%
2024-09-30
$1.71B
$-9.79B
-17.43%
2024-06-30
$1.41B
$-9.33B
-15.14%
2024-03-31
$1.32B
$-9.67B
-13.63%
2023-12-31
$1.22B
$-10.07B
-12.10%
2023-09-30
$1.42B
$-10.42B
-13.67%
2023-06-30
$1.58B
$-10.92B
-14.49%
2023-03-31
$1.53B
$-11.02B
-13.86%
2022-12-31
$1.52B
$-11.28B
-13.47%
2022-09-30
$1.69B
$-11.60B
-14.56%
2022-06-30
$1.67B
$-11.94B
-13.96%
2022-03-31
$1.83B
$-12.52B
-14.62%
2021-12-31
$1.68B
$-12.61B
-13.30%
2021-09-30
$2.00B
$-12.63B
-15.86%
2021-06-30
$1.87B
$-12.80B
-14.57%
2021-03-31
$1.64B
$-13.04B
-12.58%
2020-12-31
$1.51B
$-14.20B
-10.62%
2020-09-30
$0.77B
$-15.28B
-5.02%
2020-06-30
$0.79B
$-16.18B
-4.87%
2020-03-31
$0.92B
$-17.10B
-5.40%
2019-12-31
$0.76B
$-17.37B
-4.38%
2019-09-30
$1.08B
$-17.67B
-6.12%
2019-06-30
$0.78B
$-18.12B
-4.33%
2019-03-31
$0.93B
$-18.48B
-5.02%
2018-12-31
$0.90B
$-18.84B
-4.75%
2018-09-30
$0.16B
$-19.33B
-0.82%
2018-06-30
$0.62B
$-14.69B
-4.23%
2018-03-31
$-0.10B
$-10.22B
0.98%
2017-12-31
$0.29B
$-6.76B
-4.35%
2017-09-30
$1.03B
$-3.20B
-32.15%
2017-06-30
$0.76B
$-4.59B
-16.55%
2017-03-31
$1.32B
$-5.81B
-22.62%
2016-12-31
$1.31B
$-6.02B
-21.74%
2016-09-30
$0.98B
$-6.30B
-15.50%
2016-06-30
$1.14B
$-6.63B
-17.16%
2016-03-31
$0.81B
$-7.02B
-11.55%
2015-12-31
$0.69B
$-7.45B
-9.23%
2015-09-30
$0.70B
$-4.92B
-14.12%
2015-06-30
$0.82B
$-2.27B
-35.88%
2015-03-31
$1.08B
$0.43B
251.37%
2014-12-31
$1.15B
$3.29B
34.99%
2014-09-30
$1.19B
$3.30B
35.90%
2014-06-30
$0.97B
$3.28B
29.74%
2014-03-31
$0.95B
$3.10B
30.60%
2013-12-31
$0.94B
$2.92B
32.18%
2013-09-30
$1.29B
$2.75B
46.99%
2013-06-30
$1.49B
$2.54B
58.77%
2013-03-31
$1.52B
$2.46B
61.79%
2012-12-31
$1.53B
$2.46B
62.30%
2012-09-30
$1.17B
$2.57B
45.50%
2012-06-30
$1.18B
$2.77B
42.65%
2012-03-31
$1.20B
$3.10B
38.66%
2011-12-31
$1.22B
$3.32B
36.65%
2011-09-30
$1.27B
$3.48B
36.50%
2011-06-30
$1.37B
$3.76B
36.43%
2011-03-31
$1.33B
$3.78B
35.23%
2010-12-31
$1.32B
$3.85B
34.24%
2010-09-30
$1.32B
$3.93B
33.50%
2010-06-30
$1.24B
$3.93B
31.50%
2010-03-31
$1.27B
$4.01B
31.69%
2009-12-31
$1.24B
$4.01B
30.82%
2009-09-30
$1.23B
$3.96B
31.05%
2009-06-30
$1.20B
$3.90B
30.64%
2009-03-31
$1.15B
$3.84B
29.97%
2008-12-31
$1.17B
$3.84B
30.41%
2008-09-30
$1.13B
$3.76B
29.96%
2008-06-30
$1.11B
$3.61B
30.60%
2008-03-31
$1.05B
$3.41B
30.87%
2007-12-31
$1.02B
$3.23B
31.54%
2007-09-30
$0.89B
$3.09B
28.87%
2007-06-30
$0.81B
$3.00B
26.81%
2007-03-31
$0.77B
$2.88B
26.64%
2006-12-31
$0.68B
$2.76B
24.52%
2006-09-30
$0.75B
$2.72B
27.69%
2006-06-30
$0.73B
$2.62B
27.76%
2006-03-31
$0.71B
$2.59B
27.41%
2005-12-31
$0.75B
$2.61B
28.59%
2005-09-30
$0.72B
$2.58B
27.99%
2005-06-30
$0.64B
$2.52B
25.39%
2005-03-31
$0.56B
$2.43B
22.96%
2004-12-31
$0.54B
$2.34B
22.91%
2004-09-30
$0.47B
$2.24B
20.85%
2004-06-30
$0.56B
$2.20B
25.51%
2004-03-31
$0.58B
$2.15B
27.07%
2003-12-31
$0.56B
$2.03B
27.51%
2003-09-30
$0.55B
$1.91B
28.67%
2003-06-30
$0.52B
$1.76B
29.31%
2003-03-31
$0.51B
$1.67B
30.46%
2002-12-31
$0.49B
$1.60B
30.96%
2002-09-30
$0.48B
$1.55B
31.07%
2002-06-30
$0.48B
$1.51B
31.92%
2002-03-31
$0.48B
$1.43B
33.44%
2001-12-31
$0.46B
$1.35B
34.38%
2001-09-30
$0.40B
$1.26B
31.91%
2001-06-30
$0.35B
$1.15B
30.66%
2001-03-31
$0.35B
$1.07B
32.67%
2000-12-31
$0.35B
$0.99B
35.88%
2000-09-30
$0.39B
$0.91B
42.99%
2000-06-30
$0.38B
$0.84B
45.54%
2000-03-31
$0.30B
$0.81B
37.44%
1999-12-31
$0.27B
$0.79B
34.52%
1999-09-30
$0.28B
$0.82B
33.59%
1999-06-30
$0.29B
$0.85B
33.92%
1999-03-31
$0.25B
$1.01B
24.31%
1998-12-31
$0.25B
$1.08B
22.87%
1998-09-30
$0.24B
$1.12B
21.12%
1998-06-30
$0.24B
$1.16B
20.19%
1998-03-31
$0.32B
$1.05B
29.89%
1997-12-31
$0.31B
$1.07B
28.65%
1997-09-30
$0.30B
$1.10B
27.19%
1997-06-30
$0.30B
$1.13B
26.43%
1997-03-31
$0.31B
$1.15B
26.49%
1996-12-31
$0.30B
$1.15B
25.85%
1996-09-30
$0.28B
$1.15B
24.78%
1996-06-30
$0.28B
$1.16B
24.42%
1996-03-31
$0.27B
$1.18B
23.14%
1995-12-31
$0.26B
$1.19B
22.13%
1995-09-30
$0.25B
$1.18B
21.41%
1995-06-30
$0.25B
$1.19B
21.12%
1995-03-31
$0.24B
$1.20B
20.27%
1994-12-31
$0.24B
$1.20B
19.57%
1994-09-30
$0.23B
$1.22B
18.61%
1994-06-30
$0.22B
$1.21B
17.87%
1994-03-31
$0.22B
$1.24B
17.38%
1993-12-31
$0.22B
$1.28B
16.75%
1993-09-30
$0.07B
$1.32B
5.37%
1993-06-30
$0.07B
$1.35B
4.95%
1993-03-31
$0.07B
$1.33B
4.95%
1992-12-31
$0.06B
$1.31B
4.75%
1992-09-30
$0.20B
$1.28B
15.75%
1992-06-30
$0.19B
$1.24B
15.44%
1992-03-31
$0.19B
$1.21B
15.35%
1991-12-31
$0.18B
$1.18B
15.47%
1991-09-30
$0.19B
$1.14B
16.57%
1991-06-30
$0.19B
$1.11B
17.08%
1991-03-31
$0.19B
$1.07B
17.45%
1990-12-31
$0.18B
$1.03B
17.94%
1990-09-30
$0.18B
$0.99B
18.55%
1990-06-30
$0.18B
$0.94B
18.53%
1990-03-31
$0.21B
$0.91B
23.54%
1989-12-31
$0.21B
$0.88B
24.20%
1989-09-30
$0.21B
$0.85B
25.01%
1989-06-30
$0.21B
$0.83B
25.92%
1989-03-31
$0.17B
$0.81B
21.23%
1988-12-31
$0.17B
$0.79B
20.97%
1988-09-30
$0.16B
$0.76B
21.28%
1988-06-30
$0.15B
$0.71B
21.07%
1988-03-31
$0.14B
$0.68B
20.92%
1987-12-31
$0.14B
$0.66B
21.08%
1987-09-30
$0.15B
$0.65B
22.95%
Sector
Industry
Market Cap
Revenue
Medical Medical & Dental Supplies $51.228B
$21.840B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
